Channelopathies



Channelopathies


Hitoshi Horigome



INTRODUCTION

Cardiac channelopathies are a group of inheritable disorders that predispose fetuses with primarily structurally normal hearts to arrhythmias through the alteration of ion channel currents of myocardial cells. Genetic variations in these channels affect their opening and closing functions, resulting in changes in the currents across the myocardial cell membranes that can lead to life-threatening arrhythmias.

The most common (˜1/2000 individuals) cardiac channelopathy is congenital long QT syndrome (LQTS). There have been rare case reports of other cardiac channelopathies presenting in fetal life, including short QT syndrome and congenital sick sinus syndrome (SSS). Still other channelopathies including Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia (CPVT) have not yet been reported during fetal life. This chapter will describe the current knowledge about the clinical presentation and diagnosis of the channelopathies. A discussion of genetic testing for the channelopathies can be found in Part 1, Chapter 3.


PRESENTATION OF LONG QT SYNDROME IN THE FETUS

The most common presentation of LQTS during fetal life is sinus bradycardia.1,2,3,4,5,6 This bradycardia is frequently unrecognized and underappreciated because very few LQTS positive fetuses meet the obstetrical criteria for bradycardia, which is ≤110 bpm at any time during pregnancy.3 In a large study, only 17% of fetuses with genetically confirmed LQTS met the obstetrical criteria, while 70% had a fetal heart rate (FHR) < third percentile for gestational age2 (FIG. 3.6.1). The degree of bradycardia seems to vary with pathogenic variant burden. For example, fetuses with homozygous KCNQ1 variants have lower FHR than those with heterozygous KCNQ1 variants4. In addition to sinus bradycardia, torsades de pointes (TdP), the signature rhythm of LQTS, often occurs with a 2° AV block (FIG. 3.6.2) and the two are easily recognized as abnormal.7 However, TdP and/or 2° AV block occur in <25% of reported fetal LQTS cases.

There are three groups of fetuses at risk for LQTS. The first group are those with a parent carrier of a known pathogenic LQTS variant (“inherited LQTS”). In general,
the fetal presentation of inherited LQTS is mild and the arrhythmia burden is less compared with de novo LQTS. Exceptions are some familial KCNH2 variants,1,8,9,10,11 fetuses with homozygous or compound heterozygous variants, those with Jervell and Lange-Nielsen syndrome (homozygous variant of KCNQ1 or KCNE1), and fetuses with maternal mosaicism for SCN5A R1623Q.12,13,14 Recurrent stillbirth is another presentation of familial LQTS; compared to the general population stillbirths are 10 times higher in familial LQTS, and not all losses carry the family variant or have a history of TdP.15 In familial LQTS, there are some genotype-phenotype-specific features. For example, fetal bradycardia is more pronounced in LQT1 (KCNQ1) and LQT2 (KCNH2) than in LQT3 (SCN5A).






FIGURE 3.6.1 Screening of long QT syndrome (LQTS) based on fetal heart rate (FHR). If FHR 110 bpm is used for screening of LQTS, only 19% of LQTS cases are included below the screening line. However, if the third percentile line is adopted, 66% of LQTS cases are picked up. Δ, family history of LQTS; •, arrhythmia. (Reprinted from Mitchell JL, Cuneo BF, Etheridge SP, Horigome H, Weng HY, Benson DW. Fetal heart rate predictors of long QT syndrome. Circulation. 2012;126:2688-2695.)

The second group of fetuses at risk for LQTS are those presenting unexpected TdP, with or without 2° AV block (FIG. 3.6.3). These fetuses most frequently have de novo variants and can be identified as early as 19 weeks of gestation. Among these cases of early-onset LQTS with high arrhythmia burden, the two most prevalent genotypes are some KCNH2 variants in the pore regions and SCN5A R1623Q or L409P variants.1,3,16,17,18,19 The other rare but severe forms of early-onset LQTS include Timothy syndrome (CACNA1C variant)20,21,22 and calmodulinopathy (CALM1 or CALM2 variants).23 Pathogenic variants are not identified or are uncharacterized in about 30% of these severe and early onset cases.

The third group are pregnant women with a history of stillbirths or unexplained neonatal or infant deaths. Approximately 12% of sudden infant death victims carry LQTS variants.24 For example, using molecular autopsy, Crotti et al25 found LQTS-associated gene variants in 8.8% of fetal demise. The role of LQTS-variants in stillbirths has yet to
be determined, but obstetricians, perinatal health providers, and cardiologists should be aware of these early-onset life-threatening types of LQTS and consider molecular autopsy when confronted with an unexplained stillbirth.






FIGURE 3.6.2 2° atrioventricular block observed in a fetus with long QT syndrome. A: Pulsed Doppler waveforms of ejection flow in the fetal aorta, showing fixed A-A (p-p) intervals with alternate atrioventricular (AV) conduction (2:1 AV block) due to extremely prolonged refractory period of the ventricle. The A rate is 106 bpm, and V rate is 53 bpm. SVC, inverse flow due to atrial contraction in the superior vena cava; Ao, ejection flow due to ventricular contraction in the aorta. B: Electrocardiogram recorded after birth in the same patient as A. Findings show that half of the P-waves are located on the T-waves without AV conduction due to extremely prolonged QT intervals (700 ms). PP (0.62 s) and VV (1.25 s) intervals are both regular.


Literature Summary of Fetal LQTS Presentation (Table 3.6.1)

A search of English-language journals for case reports or series of LQTS diagnosed in utero revealed 55 cases, including 10 cases with LQT1, 23 with LQT2, 15 with LQT3, 3 with calmodulinopathy, 3 unknown, and 1 with multiple pathogenic variants. Investigation of the genotype-phenotype correlations revealed that all LQT1 fetuses showed only sinus bradycardia, whereas the frequencies of 2:1 AV block and TdP reached
approximately 60% and 80%, respectively, in both LQT2 and LQT3 fetuses. Babies with LQT2 and LQT3 were delivered at a gestational age of 27 to 38 (median 35) weeks, via cesarean delivery in ˜75% of the pregnancies of which one-third were emergency cesarean deliveries.






FIGURE 3.6.3 Torsade de pointes (TdP) observed in a fetus with long QT syndrome. A: M-mode fetal echocardiogram. The atrial wall movement is faster than that of the ventricular wall without any correlations, indicating ventricular tachycardia. Ventricular wall motion is a little irregular with a rate of 210 bpm. IVS, interventricular septum. B: Typical waveforms of TdP recorded with fetal magnetocardiography, showing polymorphic ventricular tachycardia (VT) with an irregular rhythm and QRS morphology. C: Pulsed Doppler waveforms of ejection flow in the fetal aorta, showing irregular intervals and amplitudes, which suggest polymorphic VT (TdP).











TABLE 3.6.1 LITERATURE SUMMARY OF FETAL LONG QT SYNDROME








































































































































































































































































































































































































































































































































Author (y)


Origin of LQTS


Hx of Fetal Loss


GA (wk)


Rhythm


Delivery (wk)


Variant


1. Vigliani (1995)


Mother


ND


38


Brady


VD (40)


ND


2. Donofrio (1999)



ND


32


Brady



ND


3. Hamada (1999)


Mother


No


37


Brady


VD (38)


KCNQ1 A341V


4. Cuneo (2003)


De novo


No


30


VT, 2:1 AV block, SB (110 bpm)


CS (34)


SCN5A R1623Q


5. Johnson (2003)


Mother


ND


38


VT, SB (120 bpm)


ND (38)


KCNH2 R725Q


6. Miller (2004)


Maternal mosaicism


SB × 2


28


VT2, SB, 2:1 AV block


ECS (32)


SCN5A R1623Q


7. Chang (2004)


De novo


ND


ND


Tachy-brady


ND (38)


SCN5A V1763M


8. Lupoglazoff (2004)


Mother


ND


˜30


2:1 AV block


ND


KCNH2 T613M


9.


Mother


ND


˜30


VT, 2:1 AV block


ND


KCNH2 D501N


10.


M + F


ND


˜30


VT, 2:1 AV block


ND


Multiple


11.


De novo


ND


˜30


VT, 2:1 AV block


ND


KCNH2 G628S


12.


De novo


ND


˜30


VT, 2:1 AV block


ND


KCNH2 Y93C


13.


Mother


ND


˜30


SB


ND


KCNQ1 R231C


14.


Mother


ND


˜30


SB


ND


KCNQ1 G325R


15.


Mother


ND


˜30


SB


ND


KCNQ1 R231C


16.


Mother


ND


˜30


SB


ND


KCNQ1 R231C


17.


Mother


ND


˜30


SB


ND


KCNQ1 G1258 insA


18. Schultz-Bahr (2004)


De novo


Primip


ND


Tachy-brady


CS (35)


SCN5A P1332L


19. Schneider (2005)


Mother


ND


32


SB


VD (38)


KCNQ1 CTG to CCG


20. Ten Harkel (2005)


De novo


ND


29


Irregular


CS (33)


SCN5A R1623Q


21. Tomek (2008)


Father


Primip


22


2° AV block, SB





26


VT


CS (31)


SCN5A ND


22. Bhuiyan (2008)


M + F Consanguineous


MC × 2 SB × 2 homoz


22


2:1 AV block





29


PVC, VT


CS (32)


Homoz KCNH2 Q1070X


23. Wang (2008)


Novel de novo



32


Arrhythmia


ECS (32)



Novel de novo



34


VT


ND


SCN5A G1631D


24. Simpson (2009)


De novo


No


30


VT1,2,3


ND (32)


KCNH2 T613M


25. Horigome (2010)


+ FH


ND


ND


SB


ND


KCNQ1 Thr587Met


26.


? de novo


ND


ND


SB


ND


KCNQ1 Ala341Val


27.


? de novo


ND


ND


VT, 2:1 AV block


ND


KCNH2 Gly628Ser


28.


? de novo


ND


ND


VT


ND


KCNH2 Del(7) (q32qter)


29.


+ FH


ND


ND


ND


ND


KCNH2 Ser243 + 112x


30.


? de novo


ND


ND


VT, 2:1 AV block


ND


KCNH2 GM628Ala


31.


? de novo


ND


ND


VT, 2:1 AV block


ND


KCNH2 Thr613met


32.


? de novo


ND


28


2:1 AV block


ND


SCN5A Ala1186Thr


33.


? de novo


ND


ND


VT, 2:1 AV block


ND


SCN5A Asn1774Asp


34. Murphy (2011)


De novo


No


19


VT1,2,3


FD(25)


SCN5A L409B


35. Donofrio (2012)


De novo


No


19


Irregular





26


2:1 AV block





30


VT1,2, 2:1 AV block


ECS (30)


SCN5A R1623Q


36. Chabaneix (2012)


ND (but no FH)


No


36


PVCs, VT, SB (120 bpm)





37


VT1, 2:1 AV block


ND (37)


KCHN2 Gly628Ser


37. Kormarlu (2012)


Father


Primip



Tachy1,2,3


ECS


KCNH2 ND


38. Theeuws (2013)


De novo


No


32


VT1,2,3


ECS (32)


UK


39. Crotti (2013)


De novo


No


21


SB (110 bpm)





27


SB (90 bpm)


CS (37)


CALM2 D96V


40. Cuneo (2013)


De novo


ND


28


VT, 2:1 AV block


CS (33)


KCNH2 G628S


41.


Mother novel


1 SB


34


VT, 2:1 AV block


NSVD (38)


KCNH2


Thr613Lys


Lys897Thr


42.


De novo


ND


30


VT, 2:1 AV block


CS (35)


SCN5A R1623Q


43.


De novo twins


ND


30


VT1,3, 2:1 AV block


ECS (31)


SCN5A R1623Q


44. Flock (2014)


Mother


Prim


29


SB


CS (39)


KCNQ1 G350V


45.


De novo


No


27


VT1,2,3, SB, 2:1 AV block


ECS (27)


KCNH2 G682S


46.


Mother


Prim


27


SB, 2:1 AV block


CS (38)


KCNH2 T613M


47. Priest (2014)


Father


No


ND


Brady


CS (38)


KCNH2 T613M


48. Reed (2015)


De novo


No



Brady


VD (38)


CALM3 D130G


49. Chaix (2016)


De novo


30



SB (109 bpm)




36



2:1 AV block




37



SB (85 bpm)


CS (37)


CALM3


50. Magnusson (2017)


Mother


MC × 1 SB × 1


ND


ND


VD


SCN5A C1231G>A


51. Blais (2017)


De novo


No


26


VT, 2:1 AV block


CS (37)


SCN5A R1623Q


52. Miyake (2017)


De novo


MC × 1


28


2:1 AV block





30


VT3, SB


CS (35)


KCNH2 S624R


53.


Father


ND


24


VT, SB





26


VT3, SB


CS (37)


KCNH2 T613M


54. Tuveng (2018)


Mother, novel variant


Fetal loss × 1


ND


SB


ND


KCNH2 R62Q


55. Crimmins (2018)


De novo


None


27


VT, 2:1 AV block


CS (30)


KCNH2 G628S


Brady, bradycardia; CS, cesarean section; ECS, emergency cesarean section; FD, fetal demise; +FH, positive family history; homoz, homozygous for the LQTS variant; M + F, mother and father; MC, miscarriage; ND, no data; prim, primiparous mother; SB, sinus bradycardia; Tachy-brady, tachycardia and bradycardia; UK, tested for common variants but negative; VD, vaginal delivery; VT, ventricular tachycardia; 1, cardiac dysfunction; 2, biventricular hypertrophy; 3, hydrops.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Dec 30, 2020 | Posted by in CARDIOLOGY | Comments Off on Channelopathies

Full access? Get Clinical Tree

Get Clinical Tree app for offline access